EXPD vs VYNE · P/E 26, rev $6.29B vs rev $501.0K
Expeditors International of Washington, Inc. (EXPD) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the EXPD and VYNE stock pages for the full models.
Not investment advice.